Peter Bobbert

527 total citations
19 papers, 417 citations indexed

About

Peter Bobbert is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Peter Bobbert has authored 19 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Peter Bobbert's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Blood properties and coagulation (3 papers). Peter Bobbert is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Blood properties and coagulation (3 papers). Peter Bobbert collaborates with scholars based in Germany, United States and Switzerland. Peter Bobbert's co-authors include Ursula Rauch, Heinz‐Peter Schultheiß, Carsten Skurk, Thomas Bobbert, Alice Weithäuser, Wolfgang Poller, Heinz‐Peter Schultheiss, Uwe Kühl, Daniel Steffens and Silvio Antoniak and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Biochemical Pharmacology.

In The Last Decade

Peter Bobbert

19 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bobbert Germany 12 211 104 102 57 55 19 417
Andrzej Kułach Poland 11 136 0.6× 104 1.0× 56 0.5× 61 1.1× 31 0.6× 38 351
Alf‐Åge R. Pettersen Norway 13 233 1.1× 112 1.1× 73 0.7× 87 1.5× 42 0.8× 22 485
Ikuo Misumi Japan 7 238 1.1× 76 0.7× 78 0.8× 110 1.9× 28 0.5× 26 445
Rika Araki Japan 11 214 1.0× 97 0.9× 64 0.6× 104 1.8× 49 0.9× 19 459
Guanming Qi China 11 156 0.7× 112 1.1× 137 1.3× 59 1.0× 45 0.8× 23 460
Tomohiro Sakamoto Japan 10 170 0.8× 58 0.6× 62 0.6× 87 1.5× 48 0.9× 11 370
Eleonora Devangelio Italy 6 109 0.5× 85 0.8× 67 0.7× 50 0.9× 40 0.7× 6 387
Rafał Nikodem Wlazeł Poland 11 122 0.6× 83 0.8× 174 1.7× 56 1.0× 119 2.2× 24 485
Oki Takeuchi Japan 7 133 0.6× 132 1.3× 41 0.4× 74 1.3× 133 2.4× 9 553
Rui‐Xiang Zeng China 12 161 0.8× 41 0.4× 63 0.6× 91 1.6× 47 0.9× 34 408

Countries citing papers authored by Peter Bobbert

Since Specialization
Citations

This map shows the geographic impact of Peter Bobbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bobbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bobbert more than expected).

Fields of papers citing papers by Peter Bobbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bobbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bobbert. The network helps show where Peter Bobbert may publish in the future.

Co-authorship network of co-authors of Peter Bobbert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bobbert. A scholar is included among the top collaborators of Peter Bobbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bobbert. Peter Bobbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Vincent‐Höper, Sylvie, et al.. (2020). Arbeitsbelastung im Krankenhaus: Gemeinsam gegen die Ökonomie. 117. 5 indexed citations
3.
Friebel, Julian, Alice Weithäuser, Marco Witkowski, et al.. (2019). Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction. European Heart Journal. 40(40). 3318–3332. 51 indexed citations
4.
Meyer, Alexander, et al.. (2016). Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease. Cardiovascular revascularization medicine. 17(3). 169–175. 5 indexed citations
5.
Steffens, Daniel, et al.. (2015). The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study. Cardiovascular Diabetology. 14(1). 15–15. 38 indexed citations
6.
Bobbert, Peter, Uwe Kühl, Wolfgang Poller, et al.. (2014). Nicotinamide Phosphoribosyltransferase/Pre–B-Cell Colony Enhancing Factor/Visfatin Plasma Levels and Clinical Outcome in Patients With Dilated Cardiomyopathy. Journal of Cardiac Failure. 21(4). 330–338. 5 indexed citations
7.
Arntz, H.-R., et al.. (2014). Der Notarzt im Altenheim – Vorurteil und Wirklichkeit. Notfall + Rettungsmedizin. 17(2). 131–136. 2 indexed citations
8.
Weithäuser, Alice, Peter Bobbert, Silvio Antoniak, et al.. (2013). Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis. Journal of the American College of Cardiology. 62(19). 1737–1745. 57 indexed citations
9.
Bobbert, Peter, Caroline Schmidt‐Lucke, Carsten Skurk, et al.. (2013). Platelet activation and thrombus formation relates to the presence of myocardial inflammation in patients with cardiomyopathy. Journal of Cardiology. 63(5). 379–384. 12 indexed citations
10.
Mochmann, Hans‐Christian, Hans-Richard Arntz, Falk von Dincklage, et al.. (2013). Old age and chronic disease. European Journal of Emergency Medicine. 21(2). 105–111. 3 indexed citations
11.
Bobbert, Peter, et al.. (2012). Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy. Blood Coagulation & Fibrinolysis. 23(8). 723–728. 22 indexed citations
12.
Bobbert, Peter, Alexander Jenke, Thomas Bobbert, et al.. (2012). High Leptin and Resistin Expression in Chronic Heart Failure: Adverse Outcome in Patients with Dilated and Inflammatory Cardiomyopathy. European Journal of Heart Failure. 14(11). 1265–1275. 58 indexed citations
13.
Bobbert, Peter, Carmen Scheibenbogen, Alexander Jenke, et al.. (2011). Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. European Heart Journal. 32(9). 1134–1147. 43 indexed citations
14.
Bobbert, Peter, Andreas Eisenreich, Alice Weithäuser, Heinz‐Peter Schultheiß, & Ursula Rauch. (2011). Leptin and resistin induce increased procoagulability in diabetes mellitus. Cytokine. 56(2). 332–337. 13 indexed citations
15.
Pepke, Wojciech, Andreas Eisenreich, Peter Bobbert, et al.. (2011). Bivalirudin Inhibits Periprocedural Platelet Function and Tissue Factor Expression of Human Smooth Muscle Cells. Cardiovascular Therapeutics. 31(2). 115–123. 16 indexed citations
16.
Bobbert, Peter, Alice Weithäuser, Janin Andres, et al.. (2009). Increased Plasma Retinol Binding Protein 4 Levels in Patients with Inflammatory Cardiomyopathy. European Journal of Heart Failure. 11(12). 1163–1168. 39 indexed citations
17.
Bobbert, Peter, et al.. (2008). Diadenosine polyphosphates Ap3A and Ap4A, but not Ap5A or Ap6A, induce proliferation of vascular smooth muscle cells. Biochemical Pharmacology. 75(10). 1966–1973. 14 indexed citations
18.
Bobbert, Peter, Ursula Rauch, Bernd Stratmann, et al.. (2008). High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 82(2). 179–184. 6 indexed citations
19.
Bobbert, Peter, Silvio Antoniak, Heinz‐Peter Schultheiss, & Ursula Rauch. (2007). Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. Journal of Molecular and Cellular Cardiology. 44(2). 388–394. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026